Journal: International journal of cancer
Article Title: Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells.
doi: 10.1002/ijc.20838
Figure Lengend Snippet: FIGURE 3 – p53 C-terminal peptide-induced cell death: apoptosis vs. necrosis. (A) DAPI staining in human breast non-malignant cells MCF10-2A (wt p53) and malignant cells MDA-MB-468 (mutant p53). Cells were treated with 30 M p53p-Ant for the indicated times and nuclear morphology was analyzed by DAPI staining. Number of apoptotic cells with nuclear morphology typical of apoptosis were scored in at least 400 cells in each sample by fluorescence microscopy. All microscopy experiments were carried out by a blinded reader to the actual groups. Data represent mean and SD of triplicate experiments. (b) LDH assay in human breast malignant cells MDA-MB-468 (mutant p53) and MCF-7 (wt p53). Cells were untreated or treated with 30 M p53p-Ant (C-terminal peptide, aa 361–382) or p53(15)Ant (N-terminal peptide, aa 12–26) for 1 hr. LDH released into the surrounding media was determined according to manufacturer’s instructions (Promega, Madison, WI). Results are expressed as a percentage of the maximum LDH re- lease, determined by cell fractionation by repeated freeze-thawing. The p53 N-terminal peptide, which only induced necrosis without apoptosis, was used as a positive control for necrosis.36,37 Data represent mean and SD of triplicate experiments.
Article Snippet: Normal human colon cell line CCD-33Co (wild-type p53), non-malignant human breast cell line MCF10-2A (wild-type p53), malignant human breast cell lines MCF-7 (wild-type p53), MDA-MB-468 (mutant p53), MDA-MB-231 (mutant p53) and MDA-MB-157 (null p53) and human lung cancer cell line H1299 (null p53) were obtained from ATCC.
Techniques: Staining, Mutagenesis, Microscopy, Lactate Dehydrogenase Assay, Cell Fractionation, Positive Control